Incidence of Pure Red Cell Aplasia Post Allogenic Hematopoietic Stem Cell Transplant in Patients with Major ABO Mismatch in Post Cytoxan Era — a Single Center Analysis | Synapse
March 3, 2026
Incidence of Pure Red Cell Aplasia Post Allogenic Hematopoietic Stem Cell Transplant in Patients with Major ABO Mismatch in Post Cytoxan Era — a Single Center Analysis
Puntos clave
Pure red cell aplasia occurs frequently following allogenic hematopoietic stem cell transplant.
The analysis indicates a significant incidence rate of pure red cell aplasia in ABO mismatched patients.
Observational analysis at a single center examined post-transplant outcomes in patients receiving cyclophosphamide.
Highlights the need for careful monitoring and management strategies in this patient population.